These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2221861)

  • 1. Mode of action of tubulozoles against Plasmodium falciparum in vitro.
    Dieckmann-Schuppert A; Franklin RM
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1529-34. PubMed ID: 2221861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of microtubule inhibitors on protein synthesis in Plasmodium falciparum.
    Bell A; Wernli B; Franklin RM
    Parasitol Res; 1993; 79(2):146-52. PubMed ID: 8475033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounds binding to cytoskeletal proteins are active against Plasmodium falciparum in vitro.
    Dieckmann-Schuppert A; Franklin RM
    Cell Biol Int Rep; 1989 May; 13(5):411-8. PubMed ID: 2670249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compounds binding to cytoskeletal proteins are active against Plasmodium falciparum in vitro.
    Dieckmann-Schuppert A; Franklin RM
    Cell Biol Int Rep; 1989 Feb; 13(2):207-14. PubMed ID: 2655935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parasite proteases and antimalarial activities of protease inhibitors.
    Vander Jagt DL; Caughey WS; Campos NM; Hunsaker LA; Zanner MA
    Prog Clin Biol Res; 1989; 313():105-18. PubMed ID: 2675111
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the anti-microtubule compound tubulozole on Leishmania protozoan parasites in vitro.
    Fong D
    FEMS Microbiol Lett; 1993 Feb; 107(1):95-9. PubMed ID: 8468004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
    Robinson MW; Trudgett A; Hoey EM; Fairweather I
    Parasitol Res; 2003 Sep; 91(2):117-29. PubMed ID: 12910417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the effect of tunicamycin on erythrocytic stages of Plasmodium falciparum.
    Dieckmann-Schuppert A; Hensel J; Schwarz RT
    Biochem Soc Trans; 1992 May; 20(2):184S. PubMed ID: 1290509
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of tubulozole, a new synthetic microtubule inhibitor, on the induction of casein gene expression by prolactin.
    Servely JL; Geuens GM; Martel P; Houdebine LM; de Brabander M
    Biol Cell; 1987; 59(2):121-7. PubMed ID: 2957009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubulozole: a new stereoselective microtubule inhibitor.
    De Brabander M; Geuens G; Nuydens R; Willebrords R; Moeremans M; Van Ginckel R; Distelmans W; Dragonetti C; Mareel M
    Ann N Y Acad Sci; 1986; 466():757-66. PubMed ID: 3460448
    [No Abstract]   [Full Text] [Related]  

  • 11. Transition state mimetics of the Plasmodium export element are potent inhibitors of Plasmepsin V from P. falciparum and P. vivax.
    Sleebs BE; Gazdik M; O'Neill MT; Rajasekaran P; Lopaticki S; Lackovic K; Lowes K; Smith BJ; Cowman AF; Boddey JA
    J Med Chem; 2014 Sep; 57(18):7644-62. PubMed ID: 25167370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maduramicin Rapidly Eliminates Malaria Parasites and Potentiates the Gametocytocidal Activity of the Pyrazoleamide PA21A050.
    Maron MI; Magle CT; Czesny B; Turturice BA; Huang R; Zheng W; Vaidya AB; Williamson KC
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1492-9. PubMed ID: 26711768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of camptothecin, a topoisomerase I inhibitor, on Plasmodium falciparum.
    Bodley AL; Cumming JN; Shapiro TA
    Biochem Pharmacol; 1998 Mar; 55(5):709-11. PubMed ID: 9515582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
    Naughton JA; Nasizadeh S; Bell A
    Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity.
    Levatić J; Pavić K; Perković I; Uzelac L; Ester K; Kralj M; Kaiser M; Rottmann M; Supek F; Zorc B
    Eur J Med Chem; 2018 Feb; 146():651-667. PubMed ID: 29407988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tubulozole on the microtubule system of cells in culture and in vivo.
    Geuens GM; Nuydens RM; Willebrords RE; Van de Veire RM; Goossens F; Dragonetti CH; Mareel MM; De Brabander MJ
    Cancer Res; 1985 Feb; 45(2):733-42. PubMed ID: 3967244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum.
    Vaidya AB; Morrisey JM; Zhang Z; Das S; Daly TM; Otto TD; Spillman NJ; Wyvratt M; Siegl P; Marfurt J; Wirjanata G; Sebayang BF; Price RN; Chatterjee A; Nagle A; Stasiak M; Charman SA; Angulo-Barturen I; Ferrer S; Belén Jiménez-Díaz M; Martínez MS; Gamo FJ; Avery VM; Ruecker A; Delves M; Kirk K; Berriman M; Kortagere S; Burrows J; Fan E; Bergman LW
    Nat Commun; 2014 Nov; 5():5521. PubMed ID: 25422853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial synergy of cysteine and aspartic protease inhibitors.
    Semenov A; Olson JE; Rosenthal PJ
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2254-8. PubMed ID: 9736544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
    González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
    Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, antimalarial evaluation and molecular modeling studies of hydroxyethylpiperazines, potential aspartyl protease inhibitors, part 2.
    Cunico W; Gomes CR; Facchinetti V; Moreth M; Penido C; Henriques MG; Varotti FP; Krettli LG; Krettli AU; da Silva FS; Caffarena ER; de Magalhães CS
    Eur J Med Chem; 2009 Sep; 44(9):3816-20. PubMed ID: 19403210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.